Skip to main content
. 2021 Mar 31;8:637647. doi: 10.3389/fmed.2021.637647

Figure 2.

Figure 2

Standardized Mean Differences in Patient Characteristics Before and After Matching. (A) shows the results for patients diagnosed with COVID-19. (B) shows the results for patients diagnosed with COVID-19 plus suspected COVID-19 patients. Top panel show data for any α1-AR antagonists; bottom panels show data for doxazosin.